Elevated concentrations of serum creatine kinase are found in all types of muscular dystrophy and disease involving the destruction of muscle tissues. In the case of progressive muscular dystrophy, elevated CK concentrations may be present before clinical symptoms appear. Elevated CK concentrations are observed after myocardial infarction and in cases of acute cardiovascular disease and Reye’s Syndrome. Neurogenic muscle diseases such as multiple sclerosis and polio do not produce elevated CK concentrations. CK activity is in inverse relation to thyroid activity, thus, in cases of hypothyroidism, elevated concentrations of CK would be observed.
Features and Benefits
CREATINE KINASE (CK)-SL
- For the measurement of creatine kinase.
- Two part, stable liquid; ready to use reagent. Easy to use, no additional reagent preparation required.
- Wide linear range. Reduces repeat testing and the need for sample dilutions.
- No significant interference displayed from samples with elevated levels of icterus or lipemia. High reliability of testing.
- Applicable to multiple chemistry platforms. Flexible laboratory testing.
|CREATINE KINASE-SL||326-10||1x100 mL (R1); 1x25 mL (R2)|